DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Attend the virtual annual meeting on June 3, 2026 to vote on the board's recommendations. The proposals are standard governance matters with no immediate financial impact.
Final — all horizons settled through T+60d
KROS ▼ -8.22% at T+60d
NEUTRAL call ✗ call lost -8.22% · α vs SPY -13.24% · entry $11.56 → $10.61
T+1d
-0.43%
call -0.43% · α -1.22%
$11.51
settled 5mo ago
T+5d
-3.98%
call -3.98% · α -5.46%
$11.10
settled 5mo ago
T+20d
-5.02%
call -5.02% · α -9.65%
$10.98
settled 5mo ago
T+60d
-8.22%
call -8.22% · α -13.24%
$10.61
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Keros Therapeutics is holding its 2026 annual shareholder meeting virtually on June 3, 2026. The board recommends voting for the election of Jean-Jacques Bienaimé and Charles Newton as Class III directors, ratifying Deloitte & Touche LLP as auditors, and approving executive compensation.
Key Facts
- Annual meeting date: June 3, 2026
- Meeting will be held virtually
- Board recommends voting FOR all proposals
- Proposal 1: Elect Jean-Jacques Bienaimé and Charles Newton as Class III directors
- Proposal 2: Ratify Deloitte & Touche LLP as independent registered public accounting firm
- Proposal 3: Approve executive officer compensation
Financial Impact
Routine governance matters
director_electionauditor_ratificationexecutive_compensation
Risk Factors
- Failure to ratify auditors could lead to regulatory issues
- Shareholder opposition to executive compensation could signal governance concerns
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-046801 |
| Document: 0001104659-26-046801-index-headers.html | 0001104659-26-046801 |
| Document: 0001104659-26-046801-index.html | 0001104659-26-046801 |
| Document: 0001104659-26-046801.txt | 0001104659-26-046801 |
17 reports for KROS
100% Hit rate best @ T+5▲ +10.72%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 23d ago | 8-K | $11.31 $11.04 | ▼ −2.39% | ▼ −2.05% | $11.17 (−1.24%) |
Aug 20, 2026 6w ago | Insider Cluster | $10.95 $11.23 | ▲ +2.56% | ▲ +1.44% | $11.17 (+2.01%) |
Aug 3, 2026 8w ago | 8-K | $10.25 $10.64 | ▲ +3.80% | ▲ +3.90% | $11.17 (+8.98%) |
Aug 3, 2026 8w ago | Press Release | $10.25 $10.64 | ▲ +3.80% | ▲ +3.90% | $11.17 (+8.98%) |
Jul 30, 2026 9w ago | 8-K | $10.07 $11.15 | ▲ +10.72% | ▲ +7.21% | $11.17 (+10.92%) |
Jul 22, 2026 10w ago | 8-K | $10.14 $10.22 | ▲ +0.79% | ▲ +0.31% | $11.17 (+10.16%) |
Jun 17, 2026 15w ago | Insider Cluster | $10.65 $10.41 | ▼ −2.25% | ▼ −0.59% | $11.17 (+4.88%) |
Jun 8, 2026 16w ago | Insider Cluster | $10.07 $10.24 | ▲ +1.69% | ▼ −0.72% | $11.17 (+10.92%) |
May 14, 2026 20w ago | 8-K | $10.99 $11.22 | ▼ −2.09% | ▼ −2.81% | $11.17 (−1.64%) |
May 14, 2026 20w ago | Press Release | $10.99 $11.22 | ▼ −2.09% | ▼ −2.81% | $11.17 (−1.64%) |
Showing 10 of 17
US Market Status
Market Open — Closes in 3h 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access